Infliximab in refractory spondyloarthropathies: a multicentre 38 week open study

Ann Rheum Dis. 2003 Dec;62(12):1239-40. doi: 10.1136/ard.2002.004879.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Multicenter Study

MeSH terms

  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Antirheumatic Agents / therapeutic use*
  • Drug Resistance
  • Female
  • Humans
  • Infliximab
  • Male
  • Prospective Studies
  • Spondylarthropathies / drug therapy*
  • Thoracic Vertebrae*

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Infliximab